Image: Shutterstock
November 20, 2023 02:52 PM EST
Pharma
Marketing

Phar­ma com­pa­nies qui­et about ad plans on X amid de­par­ture of ma­jor con­sumer brands

Beth Snyder Bulik

Senior Editor

Phar­ma com­pa­nies are large­ly stay­ing qui­et about whether they plan to stop ad­ver­tis­ing or change their me­dia strate­gies on X af­ter sev­er­al ma­jor con­sumer brands …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times